United Services Automobile Association Jounce Therapeutics, Inc. Transaction History

United Services Automobile Association

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$3.33 - $4.93 $102,147 - $151,227	-30,675 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$4.3 - $6.73 $9,460 - $14,806	-2,200 Reduced 6.69%	30,675 $152,000
Q1 2019 May 13, 2019	SELL	$3.43 - $6.87 $10,290 - $20,610	-3,000 Reduced 8.36%	32,875 $204,000
Q4 2018 Feb 13, 2019	SELL	$2.69 - $6.71 $5,649 - $14,091	-2,100 Reduced 5.53%	35,875 $121,000
Q3 2018 Nov 13, 2018	SELL	$6.5 - $8.37 $12,116 - $15,601	-1,864 Reduced 4.68%	37,975 $247,000
Q2 2018 Aug 10, 2018	BUY	$7.27 - $21.88 $6,048 - $18,204	832 Added 2.13%	39,839 $305,000
Q1 2018 May 14, 2018	BUY	$13.4 - $28.4 $25,553 - $54,158	1,907 Added 5.14%	39,007 $872,000
Q4 2017 Feb 14, 2018	BUY	$12.52 - $17.82 $464,492 - $661,122	37,100	37,100 $473,000

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.